The Stroke Foundation is a national charity that partners with the community to prevent, treat and beat stroke. We stand alongside
stroke survivors and their families, healthcare professionals and researchers. We build community awareness and foster new thinking and
innovative treatments. We support surv...
Cílem tohoto KDP je poskytnout nástroj pro rozhodování o sekundární prevenci ischemické cévní mozkové příhody (iCMP) nebo tranzitorní ischemické ataky (TIA) u pacientů s otevřeným foramen ovale (PFO) a o péči o pacienty s CMP a hypertenzí na základě nejlepších dostupných důkazů...
This guideline covers diagnosing and managing atrial fibrillation in adults. It includes guidance on
providing the best care and treatment for people with atrial fibrillation, including assessing and
managing risks of stroke and bleeding.
The recommendations in this guideline were developed before the CO...
This guideline covers diagnosing and managing atrial fibrillation in adults. It includes guidance on providing the best care and treatment for people with atrial fibrillation, including assessing and managing risks of stroke and bleeding.
The recommendations in this guideline were developed before the C...
Andrade, J. G;
Aguilar, M;
Atzema, C;
Bell, A;
Cairns, J. A;
Cheung, C. C;
Cox, JL;
Dorian, P;
Gladstone, D. J;
Healey, J. S;
Khairy, P;
Leblanc, K;
McMurtry, M. S;
Mitchell, L. B;
Nair, G. M;
Nattel, S;
Parkash, R;
Pilote, L;
Sandhu, R. K;
Sarrazin, J. F;
Sharma, M;
Skanes, A. C;
Talajic, M;
Tsang, T. S. M;
Verma, A;
Verma, S;
Whitlock, R;
Wyse, D. G;
Macle, L.
The Canadian Cardiovascular Society (CCS) atrial fibrillation (AF) guidelines program was developed to aid clinicians in the management of these complex patients, as well as to provide direction to policy makers and health care systems regarding related issues. The most recent comprehensive CCS AF guidel...
Fibrillation auriculaire/diagnostic,
Fibrillation auriculaire/thérapie,
Fibrillation auriculaire/épidémiologie,
Fibrillation auriculaire/classification,
Facteurs de risque,
Accident vasculaire cérébral/prévention et contrôle,
Fibrillation auriculaire/physiopathologie,
Facteurs sexuels,
Groupes à Risque,
Algorithmes,
Programme clinique
Stroke is characterised by high morbidity, mortality and disability, which seriously affects the health and safety of the people. Stroke has become a serious public health problem in China. Organisational stroke management can significantly reduce the mortality and disability rates of patients with strok...
Lanza, G;
Setacci, C;
Ricci, S;
Castelli, P;
Cremonesi, A;
Lanza, J;
Novali, C;
Pratesi, C;
Santalucia, P;
Speziale, F;
Zaninelli, A;
Gensini, G. F.
Although proof-based medicine has generated much valid evidence for the drawing up of guidelines and recommendations for best clinical practice in symptomatic and asymptomatic carotid stenosis, whether and when it is better to employ endarterectomy or stenting as the intervention of choice still remain m...
DESCRIPTION: The American College of Physicians (ACP) and the American Academy of Family Physicians (AAFP) jointly developed this guideline to present the evidence and provide clinical recommendations based on the benefits and harms of higher versus lower blood pressure targets for the treatment of hyper...
Macle, L;
Cairns, J;
Leblanc, K;
Tsang, T;
Skanes, A;
Cox, JL;
Healey, JS;
Bell, A;
Pilote, L;
Andrade, JG;
Mitchell, LB;
Atzema, C;
Gladstone, D;
Sharma, M;
Verma, S;
Connolly, S;
Dorian, P;
Parkash, R;
Talajic, M;
Nattel, S;
Verma, A.
The Canadian Cardiovascular Society (CCS) Atrial Fibrillation (AF) Guidelines Committee provides periodic reviews of new data to produce focused updates that address clinically important advances in AF management. This 2016 Focused Update deals with: (1) the management of antithrombotic therapy for AF pa...
Anticoagulants,
Cardiotoniques,
Antiagrégants plaquettaires,
Digoxine,
Magnésium,
Syndrome coronarien aigu/thérapie,
Algorithmes,
Anticoagulants/usage thérapeutique,
Auricule de l'atrium/chirurgie,
Fibrillation auriculaire,
Entraînement électrosystolique,
Cardiotoniques/effets indésirables,
Ablation par cathéter,
Cardiotoniques/administration et posologie,
Fibrillation auriculaire/thérapie,
Fibrillation auriculaire/complications,
Hémorragie/induit chimiquement,
Hémorragie/prévention et contrôle,
Magnésium/usage thérapeutique,
Intervention coronarienne percutanée,
Antiagrégants plaquettaires/usage thérapeutique,
Complications postopératoires/prévention et contrôle,
Infarctus du myocarde avec sus-décalage du segment ST/thérapie,
Accident vasculaire cérébral/prévention et contrôle,
Maladie des artères coronaires/complications,
Digoxine/administration et posologie,
Digoxine/effets indésirables,
Association de médicaments,
Inhibiteurs du facteur Xa/usage thérapeutique,
Fibrinolytiques/usage thérapeutique,
Inhibiteurs du facteur Xa
